Erlotinib
Cat. No.:YN340243
产品名称: | Erlotinib |
CAS No.: | 183321-74-6 |
Chemical Name: | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine |
Synonyms: | 埃罗替尼; CP-358774; NSC 718781; OSI-774 |
分子量: | 393.44 |
分子式: | C₂₂H₂₃N₃O₄ |
SMILES: | C#CC1=CC=CC(NC2=NC=NC3=C2C=C(C(OCCOC)=C3)OCCOC)=C1 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Erlotinib (CP-358774) 是一种直接作用的EGFR酪氨酸激酶抑制剂,对人 EGFR 的IC50为 2 nM。Erlotinib 可降低完整肿瘤细胞的 EGFR 自磷酸化,IC50为 20 nM。Erlotinib 用于非小细胞肺癌的研究。 |
IC50和靶点: | [{name:"EGFR:2 nM (IC50, Cell Free Assay)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Ciardiello, F., and Tortora, G.A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptorClin. Cancer Res.7(10),2958-2970(2001)
Moyer, J.D., Barbacci, E.G., Iwata, K.K., et al.Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinaseCancer Res.57(21),4838-4848(1997)
Herbst, R.S., and Bunn, P.A., Jr.Targeting the epidermal growth factor receptor in non-small cell lung cancerClin. Cancer Res.9(16),5813-5824(2003)